Login

Aram Mangasarian , CEO, NOXXON Pharma 00:00:00

Share On Facebook Share On Twitter

NOXXON PHARMA - Interview with CEO Aram MANGASARIAN

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Discussion on the Post-Pandemic Business Landscape with Nordic Capital's COO | Klas Tikkanen , COO, Nordic Capital.
00:10:00
Archer Materials successfully fabricates nanosize biosensor components for its biochip | Dag Skindlo, CEO, Archer LtdARCH:OSL
00:00:00
Coronary atherosclerosis - Dr. Ángel Herraiz-Adillo
00:10:00
Tinkering with Appliances to Transforming Clinical Trials|Ryan Jones,CEO,Florence Healthcare
00:00:00
Ceapro using patented technology to disrupt the natural health care products - Gilles Gagnon, President and Chief Executive Officer, Ceapro
00:10:00
Supporting the companies in the fastest and most effective ways|Xavier Niel,Founder,Kima Ventures
00:10:00
European Metals: Leading Europe's Lithium Revolution from Historic Tin Mines
00:10:00
Lance Knaack: My Path to Financial Planning | Lance Knaack, Associate Financial Planner of Syverson Strege
00:10:00
Shanta Gold Highlights Growth and Success at One-to-One Mining Conference
00:10:00
Puntilla Itata Power Plant Inauguration | Emilio Pellegrini - Chairman of Electrica Puntilla S.A.
00:10:00
ESG Trends in Mining: A Financial Perspective by Société Générale
00:10:00
El Al Israel Airlines Ltd. CEO Interview

© 2017 - Neuhu+